New shingles vaccine 'superior' but comes with a sting

PBAC to consider listing Shingrix on National Immunisation Program for herpes zoster in over-60s

The newest shingles vaccine, Shingrix, has a nearly twofold increase in injection site reactions compared with the live attenuated vaccine Zostavax, according to a systematic review.